Alnylam Pharmaceuticals (ALNY) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

ALNY is expected to report earnings to fall 263.91% to -91 cents per share on October 24

Alnylam Pharmaceuticals ALNY Stock Earnings Reports

Q3'24

Est.

$-0.92

Q2'24

Beat

by $1.61

Q1'24

Beat

by $0.98

Q4'23

Beat

by $0.49

Q3'23

Beat

by $3.06

The last earnings report on August 01 showed earnings per share of 56 cents, beating the estimate of -104 cents. With 459.54K shares outstanding, the current market capitalization sits at 35.29B.

View a ticker or compare two or three

Compare

ALNY

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ALNY
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ALNY (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of therapeutics based on RNA interference

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

675 West Kendall Street

Phone

+1 617 551-8200

Employees

2100

Web

https://www.alnylam.com